KZR-261 in Subjects With Advanced Solid Malignancies

Cancer Recurrence, Clinical Trials, Metastatic Castration Sensitive Prostate Cancer (MCSPC)

— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives

NCT Number: NCT05047536
Phase: Phase 1
Trial Summary: A first-in-human, open-label, multicenter, Phase 1 study of KZR-261 designed to assess the safety and tolerability, preliminary anti-tumor activity, and pharmacokinetics (PK) of KZ – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): Kezar Life Sciences, Inc.
Acronym:

Pin It on Pinterest